Hsin-Ta Wu
Hsin-Ta Wu
Associate Director, Bioinformatics at Natera
Potvrđena adresa e-pošte na - Početna stranica
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Cancer Genome Atlas Research Network
New England Journal of Medicine 368 (22), 2059-2074, 2013
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network Analysis working group: Baylor College ...
Nature 499 (7456), 43-49, 2013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
Integrated genomic characterization of oesophageal carcinoma
Cancer Genome Atlas Research Network
Nature 541 (7636), 169, 2017
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ...
Nature genetics 47 (2), 106-114, 2015
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer
T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ...
JAMA oncology 5 (8), 1124-1131, 2019
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ...
Cancer Research 79 (13_Supplement), 913-913, 2019
The integrated genomic landscape of thymic epithelial tumors
M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ...
Cancer cell 33 (2), 244-258. e10, 2018
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic RecurrencePersonalized ctDNA Detection of Breast Cancer Recurrence
RC Coombes, K Page, R Salari, RK Hastings, A Armstrong, S Ahmed, ...
Clinical Cancer Research 25 (14), 4255-4263, 2019
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
MDM Leiserson, HT Wu, F Vandin, BJ Raphael
Genome biology 16 (1), 1-20, 2015
An integrative probabilistic model for identification of structural variation in sequencing data
SS Sindi, S Önal, LC Peng, HT Wu, BJ Raphael
Genome biology 13 (3), 1-25, 2012
Identification of ovarian cancer metastatic miRNAs
S Vang, HT Wu, A Fischer, DH Miller, S MacLaughlan, E Douglass, ...
PloS one 8 (3), e58226, 2013
Identification of ovarian cancer metastatic miRNAs
S Vang, HT Wu, A Fischer, DH Miller, S MacLaughlan, E Douglass, ...
PloS one 8 (3), e58226, 2013
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
MJM Magbanua, LB Swigart, HT Wu, GL Hirst, C Yau, DM Wolf, A Tin, ...
Annals of Oncology 32 (2), 229-239, 2021
Identifying structural variants using linked-read sequencing data
R Elyanow, HT Wu, BJ Raphael
Bioinformatics 34 (2), 353-360, 2018
Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease
AS Brodsky, A Fischer, DH Miller, S Vang, S MacLaughlan, HT Wu, J Yu, ...
PloS one 9 (4), e94476, 2014
Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant …
MJM Magbanua, L Brown-Swigart, GL Hirst, C Yau, D Wolf, AA Ma, ...
Cancer Research 79 (4_Supplement), PD2-01-PD2-01, 2019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20